Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Tiaprofenic acid 300 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely fenbufen 300 milligram/1 each conventional release oral capsule (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Isoxsuprine hydrochloride 20 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely ibuprofen 200 milligram/1 each prolonged-release oral capsule (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Nifedipine 60 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely temozolomide 5 milligram/1 each conventional release oral capsule (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Mephobarbital 100 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Tetracycline 100 mg oral capsule |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Fenofibrate 160 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Mexiletine hydrochloride 50 mg oral capsule |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely nifedipine 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Valsartan 40 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely theophylline 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Tolfenamic acid 200 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Nadolol 20 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Levamisole 50 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Tolvaptan 15 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Griseofulvin microsize 250 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely lithium carbonate 150 milligram/1 each conventional release oral capsule (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Terfenadine 30 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Torsemide 20 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Quetiapine (as quetiapine fumarate) 200 mg prolonged-release oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Retigabine 300 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Periciazine 2.5 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Ibuprofen 100 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Quinine hydrochloride 300 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Ganciclovir 500 mg oral capsule |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Hydromorphone hydrochloride 4 mg prolonged-release oral capsule |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Ivacaftor 150 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Glyburide 6.3 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Eplerenone 100 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Flurazepam (as flurazepam hydrochloride) 15 mg oral capsule |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely furosemide 40 milligram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Prednisone 10 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Prazosin hydrochloride 1 mg oral capsule |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely nicardipine hydrochloride 20 milligram/1 each conventional release oral capsule (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Ethacrynic acid 50 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Losartan potassium 25 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Thioridazine hydrochloride 150 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely indinavir (as indinavir sulfate) 400 milligram/1 each conventional release oral capsule (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Minoxidil 5 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely mexiletine hydrochloride 200 milligram/1 each conventional release oral capsule (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Oxazepam 10 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely zolpidem tartrate 5 milligram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Lithium carbonate 600 mg oral capsule |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Terbutaline sulfate 7.5 mg prolonged-release oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely pyridostigmine bromide 60 milligram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely morphine sulfate 15 milligram/1 each conventional release rectal suppository (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Molindone hydrochloride 25 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely prednisolone 2.5 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Retigabine 400 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely methenamine hippurate 1 gram/1 each conventional release oral capsule (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Diltiazem hydrochloride 60 mg prolonged-release oral capsule |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely levonorgestrel 30 microgram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Zotepine 25 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Milnacipran hydrochloride 50 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Nalidixic acid 250 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Flurazepam (as flurazepam hydrochloride) 30 mg oral capsule |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 250 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Hydroxyzine pamoate 25 mg oral capsule |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Nicardipine hydrochloride 30 mg oral capsule |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Yohimbine hydrochloride 5.4 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely tiotixene hydrochloride 2 milligram/1 each conventional release oral capsule (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely nicotinic acid 1 gram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Losartan potassium 50 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Pantoprazole (as pantoprazole sodium sesquihydrate) 40 mg gastro-resistant oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Venlafaxine 37.5 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Fenbufen 450 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Thioridazine hydrochloride 200 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Morphine sulfate 50 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Tetracycline 500 mg oral tablet |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
céfazoline 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
céfazoline 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
un |
Inferred relationship |
Some |
1 |
céfazoline 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
Product containing precisely activated charcoal 5 gram/1 sachet conventional release oral granules (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely activated charcoal 5 gram/1 sachet conventional release oral granules (clinical drug) |
Has presentation strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
Has presentation strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
acyclovir 250 mg, fiole de poudre pour perfusion (médicament clinique) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
acyclovir 250 mg, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
amoxicilline 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
amoxicilline 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
Agalsidase beta 5 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
Agalsidase beta 5 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
céfazoline 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
céfazoline 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
céfradine 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
céfradine 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
céfradine 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
céfradine 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
céfradine 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator value (attribute) |
False |
un |
Inferred relationship |
Some |
1 |
amphotéricine 50 mg, fiole de poudre pour perfusion (médicament clinique) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
amphotéricine 50 mg, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
acyclovir 500 mg, fiole de poudre pour perfusion (médicament clinique) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
acyclovir 500 mg, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
Product containing precisely alteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
Product containing precisely alteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|